363 related articles for article (PubMed ID: 8792953)
1. The role of dornase alfa in the treatment of cystic fibrosis.
Cramer GW; Bosso JA
Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
[TBL] [Abstract][Full Text] [Related]
2. Inhaled mannitol for cystic fibrosis.
Nolan SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
[TBL] [Abstract][Full Text] [Related]
3. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
[TBL] [Abstract][Full Text] [Related]
4. Dornase alfa for cystic fibrosis.
Yang C; Chilvers M; Montgomery M; Nolan SJ
Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
[TBL] [Abstract][Full Text] [Related]
5. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
[TBL] [Abstract][Full Text] [Related]
6. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
[TBL] [Abstract][Full Text] [Related]
7. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
[TBL] [Abstract][Full Text] [Related]
8. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008649. PubMed ID: 29424930
[TBL] [Abstract][Full Text] [Related]
9. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.
Goa KL; Lamb H
Pharmacoeconomics; 1997 Sep; 12(3):409-22. PubMed ID: 10170464
[TBL] [Abstract][Full Text] [Related]
10. Dornase alfa: a new option in the management of cystic fibrosis.
Witt DM; Anderson L
Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
12. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
McCoy K; Hamilton S; Johnson C
Chest; 1996 Oct; 110(4):889-95. PubMed ID: 8874241
[TBL] [Abstract][Full Text] [Related]
13. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
[TBL] [Abstract][Full Text] [Related]
14. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA
Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
[TBL] [Abstract][Full Text] [Related]
15. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.
Shah PL; Conway S; Scott SF; Rainisio M; Wildman M; Stableforth D; Hodson ME
Respiration; 2001; 68(2):160-4. PubMed ID: 11287830
[TBL] [Abstract][Full Text] [Related]
16. Dornase alfa for cystic fibrosis.
Jones AP; Wallis C
Cochrane Database Syst Rev; 2010 Mar; (3):CD001127. PubMed ID: 20238314
[TBL] [Abstract][Full Text] [Related]
17. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
Derelle J; Bertolo-Houriez E; Marchal F; Weber M; Virion JM; Vidailhet M
Arch Pediatr; 1998 Apr; 5(4):371-7. PubMed ID: 9759155
[TBL] [Abstract][Full Text] [Related]
18. Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.
Bryson HM; Sorkin EM
Drugs; 1994 Dec; 48(6):894-906. PubMed ID: 7533697
[TBL] [Abstract][Full Text] [Related]
19. Timing of dornase alfa inhalation for cystic fibrosis.
Dentice R; Elkins M
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007923. PubMed ID: 27457496
[TBL] [Abstract][Full Text] [Related]
20. Timing of dornase alfa inhalation for cystic fibrosis.
Dentice R; Elkins M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007923. PubMed ID: 33686652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
